Krystal Biotech, Inc. (KRYS)
Across 31 earnings reports since Nov 14, 2017, Krystal Biotech, Inc. (KRYS) has a clear post-earnings pattern. It moves ±6.36% on average after reporting and finishes higher 41.9% of the time. Its largest post-earnings gain was +41.02% (Feb 26, 2024) and its largest decline was -15.05% (Nov 06, 2023). The next earnings report is predicted for 2026-11-04 (estimated).
Earnings reactions
How KRYS moved on each past earnings report.
Earnings Impact
Total Earnings
31
Avg Abs. Movement
±6.36%
Positive %
41.9%
Negative %
58.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 03, 2026 | ☀ PRE | -8.42% | open_in_new |
| Feb 17, 2026 | ☀ PRE | +4.12% | open_in_new |
| Nov 03, 2025 | ☀ PRE | +0.17% | open_in_new |
| Aug 04, 2025 | ☀ PRE | -14.04% | open_in_new |
Earnings Count
31
Total earnings in dataset
Avg Abs. Movement
±6.36%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260904 | open_in_new SEC.gov |
| 144 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 144 | 20260814 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260803 | open_in_new SEC.gov |
| 8-K | 20260803 | open_in_new SEC.gov |
| 8-K | 20260721 | open_in_new SEC.gov |
| 4 | 20260626 | open_in_new SEC.gov |
Frequently asked about KRYS earnings
When does Krystal Biotech, Inc. report earnings next? expand_more
Krystal Biotech, Inc. (KRYS)'s next earnings date is estimated for 2026-11-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does KRYS stock move after earnings? expand_more
Over 31 reports, KRYS has moved an average of ±6.36% the session after earnings, closing higher 41.9% of the time.
What was KRYS's biggest post-earnings move? expand_more
KRYS's largest post-earnings gain on record was +41.02% on Feb 26, 2024, and its largest decline was -15.05% on Nov 06, 2023.
Where can I find Krystal Biotech, Inc.'s SEC filings? expand_more
All of Krystal Biotech, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right